Table 2.
Membrane Source | Cancer Type | Membrane Type | Cargo | Efficacy | Ref. |
---|---|---|---|---|---|
Salmonella | B16F10 and 4T1 tumors |
OMV | Tegafur@F127 nanomicelles |
|
[71] |
Ehrlich ascites carcinoma (EAC) | OMV | Paclitaxel |
|
[72] | |
Escherichia coli | Human lung carcinoma A459 cells | Protoplast-derived nanovesicles | Doxorubicin |
|
[73] |
B16F10 tumor | DMV | Doxorubicin |
|
[74] | |
HER2-overexpressing HCC1954 cells | OMV | siRNA |
|
[75] | |
CT26 and 4T1 tumors | OMV | ICG |
|
[68] | |
B16F10 tumor | OMV | ICG |
|
[76] | |
TC-1 and B16F10 tumors | OMV | BFGF |
|
[77] |
Abbreviations: RGD: amino sequence of arginine, glycine, and aspartate; ICG: indocyanine green; BFGF: basic fibroblast growth factor.